A Patient Who Has Pulmonary Arterial Hypertension (PAH) Is Receiving

Multiple Choice

A patient who has pulmonary arterial hypertension (PAH) is receiving epoprostenol [Flolan] at a rate of 210 ng/min using a portable pump. The patient weighs 70 kg. The patient calls the clinic to report headache, nausea, and vomiting. The nurse will counsel the patient to:

A) decrease the infusion to 100 ng/min
B) discuss these side effects with the provider.
C) prepare for a hospital admission.
D) stop the infusion and contact the provider.